{
    "title": "Yellow fever-associated viscerotropic disease in Barcelona, Spain.",
    "doc_id": "18494699",
    "writer": "Mu√±oz J",
    "year": "2008",
    "summary": "Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been described. We report a new case of YEL-AVD. ...",
    "abstract": "Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been described. We report a new case of YEL-AVD. Given the potential risks associated with the vaccine, physicians should consider vaccination only for patients truly at risk for exposure to yellow fever, especially for primovaccination.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/18494699/",
    "clean_text": "yellow fever associated viscerotropic disease in barcelona spain yellow fever vaccine is a live attenuated viral preparation from the d virus strain since cases of yellow fever vaccine associated viscerotropic disease yel avd have been described we report a new case of yel avd yellow fever vaccine is a live attenuated viral preparation from the d virus strain since cases of yellow fever vaccine associated viscerotropic disease yel avd have been described we report a new case of yel avd given the potential risks associated with the vaccine physicians should consider vaccination only for patients truly at risk for exposure to yellow fever especially for primovaccination"
}